First Trust Advisors »

Revance Therapeutics shares owned by First Trust Advisors

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by First Trust Advisors from 13F filings

Historical chart of First Trust Advisors investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by First Trust Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by First Trust Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $950k 83k 11.47
2023-06-30 $2.8M 109k 25.31
2022-03-31 $481k 25k 19.51
2021-12-31 $942k 58k 16.32
2021-09-30 $1.5M 56k 27.85
2021-06-30 $603k 20k 29.65
2021-03-31 $2.0M 73k 27.95
2020-12-31 $945k 33k 28.35
2020-09-30 $1.4M 56k 25.13
2020-06-30 $1.4M 59k 24.42
2019-03-31 $290k 18k 15.79